DexCom, Inc. vs Impinj Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Impinj Inc trades at $177.62 (market cap $5.32B). The key difference: DexCom, Inc. is far larger — about 6.4× Impinj Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Impinj Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | PI | |
|---|---|---|
Market Cap | $33.79B | $5.32B |
Sector | Health | Technology |
52-Week High | $89.53 | $241.91 |
52-Week Low | $54.84 | $91.34 |
Enterprise Value | $33.24B | $5.45B |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →